NNSA and the Kazakhstan Customs Control Committee recently held a ceremony to commission the specialized radiation detection equipment at Astana International Airport. The ceremony recognized the effective ongoing cooperation between the U.S. and the Republic of Kazakhstan, along with the generous financial contributions from New Zealand, Norway and the Republic of Korea.
Read more: http://1.usa.gov/QMQJdb
NNSA announced that it recently completed two milestones towards production of early plutonium oxide feedstock for its Mixed Oxide (MOX) Fuel Fabrication Facility. In its second year in production, NNSA exceeded the FY 2012 goal of 200 kilograms of plutonium oxide production by disassembling nuclear weapons pits and converting them into plutonium oxide at Los Alamos National Laboratory (LANL). NNSA also initiated operations at H-Canyon and HB-Line at the Savannah River Site (SRS) to begin plutonium oxide production. The oxide production at both LANL and SRS provides the initial feedstock for the MOX facility and demonstrates the first steps towards permanent plutonium disposition.
Read more: http://1.usa.gov/RHXeuG
NNSA reached an important transformation milestone today with the successful on-time, on-budget occupancy transfer of the LEED Gold National Security Campus in Kansas City, Missouri. As the first step in moving out of a Cold War-era complex, NNSA will start paying the lease on the green manufacturing facility under a unique private/governmental partnership.
Read more: http://1.usa.gov/XJHImU
NNSA announced today that it delivered all of its scheduled W76-1 Submarine Launched Ballistic Missile warhead units to the Navy in FY 2012.
Read more: http://1.usa.gov/T3VBc5
NNSA’s Global Threat Reduction Initiative announced today the award of a cooperative agreement to further accelerate the establishment of accelerator-based technology to produce the critical medical isotope molybdenum-99 (Mo-99) in the U.S. The agreement with NorthStar Medical Radioisotopes, LLC, is important to ensuring a reliable domestic supply of Mo-99 for U.S. patients, produced without the use of highly enriched uranium.
Read more: http://1.usa.gov/WaOvpj
